Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

Robert J. Ginsberg · The Annals of Thoracic Surgery · 1995 · 3K citations

Medicine, Oncology, Surgery +12

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti et al. · Journal of Clinical Oncology · 2008 · 2.7K citations · Full text

Medicine, Oncology, Pharmacology +13

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · The Lancet Oncology · 2006 · 1.6K citations

Medicine, Oncology, Pharmacology +12

Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database

Brian E. Lally, Daniel Zelterman, Joseph M. Colasanto et al. · Journal of Clinical Oncology · 2006 · 471 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer

R. Arriagada, Ariane Dunant, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2009 · 396 citations · Full text

Medicine, Oncology, Chemotherapy +14